Filing Details

Accession Number:
0000950170-24-075718
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-20 17:00:43
Reporting Period:
2024-06-17
Accepted Time:
2024-06-20 17:00:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1652130 Intellia Therapeutics Inc. NTLA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1545794 Frank Verwiel C/O Intellia Therapeutics, Inc.
40 Erie Street; Suite 130
Cambridge MA 02139
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-06-17 1,505 $25.00 17,948 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The reported sale of 1,505 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on March 7, 2024.